Small Molecule Probes That Perturb A Protein-protein Interface In Antithrombin
Dongyue Xin1, Andreas Holzenburg2, Kevin Burgess1
1Department of Chemistry, Texas A & M University, Box 30012, College Station, TX 77842.
Chemical Science
|November 15, 2014
Summary
Small molecules were designed to disrupt protein-protein interactions by accelerating alpha-antithrombin oligomerization. This research offers insights into serpinopathies and the development of novel therapeutics.
Area of Science:
- Medicinal Chemistry
- Biochemistry
- Structural Biology
Background:
- Small molecule probes can perturb protein-protein interactions (PPIs) by inducing structural changes.
- Alpha-antithrombin, a serpin, exists in a metastable oligomeric state relevant to disease.
- Serpinopathies are associated with the formation of oligomeric serpin fibrils.
Purpose of the Study:
- To design and synthesize small molecule probes targeting the alpha-antithrombin dimer interface.
- To investigate the effect of these probes on alpha-antithrombin oligomerization.
- To explore the potential of these molecules in modulating serpin behavior relevant to disease.
Main Methods:
- Application of the Exploring Key Orientations (EKO) strategy for probe design.
- Synthesis of piperidinone-piperidine chemotype derivatives.
- Analysis of protein oligomerization using non-denaturing polyacrylamide gel electrophoresis (PAGE).
- Assay of alpha-antithrombin's inhibitor activity in a thrombin-catalyzed reaction.
- Kinetic analysis of probe-induced oligomerization.
- Molecular modeling experiments.
Main Results:
- Several synthesized derivatives of compound 1 significantly accelerated the oligomerization of monomeric alpha-antithrombin.
- Probe-induced loss of alpha-antithrombin's inhibitor activity was observed.
- Probes featuring O-benzyl-protected serine side-chains demonstrated the highest catalytic activity.
- Modeling experiments provided proposed reasons for the observed activity differences.
Conclusions:
- This study presents one of the first examples of small molecules designed to target a protein-protein interface involved in serpin oligomerization.
- The findings highlight the potential of small molecules to modulate alpha-antithrombin aggregation.
- The research has implications for understanding and potentially treating serpinopathies.


